Login to Your Account



Firm to Cut 31 R&D Jobs

CTI Shifts Focus to Zevalin with Cutbacks, Trial Delays

By Donna Young


Friday, February 1, 2008
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription